Evidence map›Paper›PMID 25386850›Full record

ArticlePloS one2014

High-throughput sequencing approach uncovers the miRNome of peritoneal endometriotic lesions and adjacent healthy tissues.

Merli Saare, Kadri Rekker, Triin Laisk-Podar, Deniss Sõritsa, Anne Mari Roost, Jaak Simm, Agne Velthut-Meikas, Külli Samuel, Tauno Metsalu, Helle Karro and 3 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. microRNA Detection via Nanostructured Biochips for Early Cancer Diagnostics.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. miRNAs in the Era of Personalized Medicine: From Biomarkers to Therapeutics.International journal of molecular sciences · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Molecular and Cellular Pathogenesis of Endometriosis.Current women's health reviews · 2018
    Review
  16. Article
  17. Article
  18. Biomarkers of Pelvic Endometriosis.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2017
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Merli SaareCompetence Centre on Reproductive Medicine and Biology, Tartu, Estonia; Department of Obstetrics and Gynecology, University of Tartu, Tartu, Estonia; Institute of Bio- and Translational Medicine, University of Tartu, Tartu, Estonia.
Kadri RekkerCompetence Centre on Reproductive Medicine and Biology, Tartu, Estonia; Department of Obstetrics and Gynecology, University of Tartu, Tartu, Estonia.
Triin Laisk-PodarCompetence Centre on Reproductive Medicine and Biology, Tartu, Estonia; Department of Obstetrics and Gynecology, University of Tartu, Tartu, Estonia.
Deniss SõritsaCompetence Centre on Reproductive Medicine and Biology, Tartu, Estonia; Tartu University Hospital's Women's Clinic, Tartu, Estonia; Elite Clinic, Sangla 63, Tartu, Estonia.
Anne Mari RoostCompetence Centre on Reproductive Medicine and Biology, Tartu, Estonia.
Jaak SimmDepartment of Electrical Engineering (ESAT), STADIUS Center for Dynamical Systems, Signal Processing and Data Analytics, KU Leuven, Leuven, Belgium; iMinds Medical IT, Leuven, Belgium; Centre for Biology of Integrated Systems, Tallinn University of Technology, Tallinn, Estonia.
Agne Velthut-MeikasCompetence Centre on Reproductive Medicine and Biology, Tartu, Estonia; Centre for Biology of Integrated Systems, Tallinn University of Technology, Tallinn, Estonia.
Külli SamuelCompetence Centre on Reproductive Medicine and Biology, Tartu, Estonia.
Tauno MetsaluInstitute of Computer Science, University of Tartu, Tartu, Estonia.
Helle KarroDepartment of Obstetrics and Gynecology, University of Tartu, Tartu, Estonia; Tartu University Hospital's Women's Clinic, Tartu, Estonia.
Andrei SõritsaElite Clinic, Sangla 63, Tartu, Estonia.
Andres SalumetsCompetence Centre on Reproductive Medicine and Biology, Tartu, Estonia; Department of Obstetrics and Gynecology, University of Tartu, Tartu, Estonia; Institute of Bio- and Translational Medicine, University of Tartu, Tartu, Estonia.
Maire PetersCompetence Centre on Reproductive Medicine and Biology, Tartu, Estonia; Department of Obstetrics and Gynecology, University of Tartu, Tartu, Estonia.
University of Tartu · EECompetence Centre on Health Technologies (Estonia) · EEiMinds · BETallinn University of Technology · EETartu University Hospital · EE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating data have shown the involvement of microRNAs (miRNAs) in endometriosis pathogenesis. In this study, we used a novel approach to determine the endometriotic lesion-specific miRNAs by high-throughput small RNA sequencing of paired samples of peritoneal endometriotic lesions and matched healthy surrounding tissues together with eutopic endometria of the same patients. We found five miRNAs specific to epithelial cells--miR-34c, miR-449a, miR-200a, miR-200b and miR-141 showing significantly higher expression in peritoneal endometriotic lesions compared to healthy peritoneal tissues. We also determined the expression levels of miR-200 family target genes E-cadherin, ZEB1 and ZEB2 and found that the expression level of E-cadherin was significantly higher in endometriotic lesions compared to healthy tissues. Further evaluation verified that studied miRNAs could be used as diagnostic markers for confirming the presence of endometrial cells in endometriotic lesion biopsy samples. Furthermore, we demonstrated that the miRNA profile of peritoneal endometriotic lesion biopsies is largely masked by the surrounding peritoneal tissue, challenging the discovery of an accurate lesion-specific miRNA profile. Taken together, our findings indicate that only particular miRNAs with a significantly higher expression in endometriotic cells can be detected from lesion biopsies, and can serve as diagnostic markers for endometriosis.

Indexed as

AdultCadherinsCase-Control StudiesEndometriosisFemaleHigh-Throughput Nucleotide SequencingHomeodomain ProteinsHumansMicroRNAsPeritoneumReference ValuesRepressor ProteinsReverse Transcriptase Polymerase Chain ReactionStromal CellsTranscription FactorsZinc Finger E-box-Binding Homeobox 1CadherinsHomeodomain ProteinsMicroRNAsMIRN141 microRNA, humanMIRN200 microRNA, humanMIRN34 microRNA, humanMIRN449 microRNA, humanRepressor ProteinsTranscription FactorsZEB1 protein, humanZEB2 protein, humanZinc Finger E-box-Binding Homeobox 1Zinc Finger E-box Binding Homeobox 2

Identifiers

PMID25386850
PMCPMC4227690
OpenAlexW1975160565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.